15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-α by decreasing levels of acetylated histone H3 and H4 at its promoter

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 88-93

  Engdahl, Ryan ^a   Monroy, M Alexandra ^a   Daly, John M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

15 Deoxy 12,14 prostaglandin J2 (15d PGJ2); Histone H3 and H4; Peroxisome proliferator activated receptor gamma (PPAR ); THP 1 monocyte macrophage; Tumor necrosis factor alpha (TNF )

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; HISTONE H3; HISTONE H4; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; DRUG DERIVATIVE; HISTONE; PROSTAGLANDIN D2; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; DRUG EFFECT; GENETICS; METABOLISM; MONOCYTE; PHYSIOLOGY; PROMOTER REGION; TRANSACTIVATION;

ACETYLATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTONES; HUMANS; MONOCYTES; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249722152     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.057     Document Type: Article

References (25)

1. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptorγ is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
2. Jiang C., Ting T.A., and Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Lett. Nat. 391 (1998) 82-86
3. Li M., Pascual G., and Glass C.K. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell Biol. 20 (2000) 4699-4707
4. 12,14-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPARγ-independent mechanism. Biochem. Biophys. Res. Commun. 302 (2003) 415-420
5. Thieringer R., Fenyk-Melody J.E., Le Grand C.B., Shelton B.A., Detmers P.A., Somers E.P., Carbin L., Moller D.E., Wright S.D., and Berger J. Activation of peroxisome proliferator-activated receptorγ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo. J. Immunol. 164 (2000) 1046-1054
6. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., and Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of Iκβ kinase. Nature 403 (2000) 103-108
7. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., and Evans R.M. PPARγ-dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7 (2001) 48-52
8. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., and Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 (2005) 707-721
9. Welch J.S., Ricote M., Akiyama T.E., Gonzalez F.J., and Glass C.K. PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFNγ target genes in macrophages. Proc. Natl. Acad. Sci. USA 100 (2003) 6712-6717
10. 12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. USA 97 (2000) 4844-4849
11. 12,14-prostaglandin J2 inhibits IL-1β-induced IKK enzymatic activity and Iκβα degradation in rat chondrocytes through a PPARγ-independent pathway. FEBS Lett. 572 (2004) 33-40
12. 12,14-prostaglandin J2 in activated murine macrophages. Mol. Cell Biol. 20 (2000) 1692-1698
13. 12,14-prostaglandin J2. Proc Natl. Acad. Sci. USA 96 (1999) 4668-4673
14. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., and Glass C.K. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPARγ. Nature 437 (2005) 759-763
15. Miao F., Gonzalo I.G., Lanting L., and Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J. Biol. Chem. 279 (2004) 18091-18097
16. Lee J.Y., Kim N.A., Sanford A., and Sullivan K.E. Histone acetylation and chromatin conformation are regulated separately at the TNF-α promoter in monocytes and macrophages. J. Leukoc. Biol. 73 (2003) 862-871
17. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
18. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000) 435-459
19. Kurdistani S.K., Tavazoie S., and Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 117 (2004) 721-733
20. Cheung W.L., Briggs S.D., and Allis C.D. Acetylation and chromosomal functions. Curr. Opin. Cell. Biol. 12 (2000) 326-333
21. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
22. 12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. Arthritis Rheum. 52 (2005) 94-104
23. Zhao G., Etherton T.D., Martin K.R., Vanden Heuvel J.P., Gillies P.J., West S.G., and Kris-Etherton P.M. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem. Biophys. Res. Commun. 336 (2005) 909-917
24. Mahlknecht U., Will J., Varin A., Hoelzer D., and Herbein G. Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression. J. Immunol. 173 (2004) 3979-3990
25. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S., Heyman R., Rose D., Glass C., and Rosenfeld M. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414